Multileaf collimators are beneficial in treating a wide range of cancers. They are particularly useful for cancers that require highly precise radiation doses, such as brain tumors, head and neck cancers, and prostate cancer. MLCs are also employed in treating lung cancer, breast cancer, and gastrointestinal cancers, where precise targeting can significantly improve outcomes.